Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare syndrome including neonatal and infantile hypotonia and failure to thrive, cystinuria type 1 and nephrolithiasis, growth retardation due to growth hormone deficiency, and minor facial dysmorphism.
Features include always present findings: Cystinuria, Failure to thrive, Feeding difficulties in infancy, and Postnatal growth retardation and others; and common findings: Seizure, Increased circulating lactate concentration, and Hypocalcemia. 35 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 6 | Low muscle tone (hypotonia), Generalized hypotonia, Muscle weakness |
Phenotype severity distribution: 10 always present features, 3 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered. Interventions under study include procedural interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
1 publication has been identified in PubMed for hypotonia-cystinuria syndrome. Research spans Other (100%).
Cuk M (2024). [PMID: 39062725](https://pubmed.ncbi.nlm.nih.gov/39062725/). *Genes (Basel)*. [Other]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 3:08 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Brain and nerves |
5 |
Seizure, Severe intellectual disability, Global developmental delay |
Growth and development | 3 | Failure to thrive, Postnatal growth retardation, Decreased response to growth hormone stimulation test |
Pregnancy and birth | 3 | Neonatal hypoglycemia, Decreased fetal movement, Neonatal hypotonia |
Head and neck | 2 | Tented upper lip vermilion, Facial palsy |
Hormones | 2 | Hypergonadotropic hypogonadism, Decreased response to growth hormone stimulation test |
Digestive system | 2 | Feeding difficulties in infancy, Excessive hunger (polyphagia) |
Lab test results | 1 | Increased circulating lactate concentration |
Eyes | 1 | Ptosis |
Kidneys and urinary system | 1 | Nephrolithiasis |
Age of onset: before birth, newborn period, at birth.
AI-curated news mentioning hypotonia-cystinuria syndrome
Updated Aug 19, 2026
Researchers identified a novel homozygous KDM5A variant linked to severe axial hypotonia, seizures, and cardiac anomalies. This discovery enhances understanding of the genetic underpinnings of these conditions.
Rare Disease Day 2026 highlights the ongoing struggles of families facing undiagnosed conditions, including hydrocephalus and Dandy-Walker syndrome. The event emphasizes the need for awareness and support for those dealing with complex health challenges.